[Problems of cervical cancer and presentation of a new ring applicator for the afterloading technic with the selectron]. 1984

J Halama, and H D Strüter, and B Rogge, and W Falk

During our radiooncologic experience, we have learned the problems caused by insufficient information on the patient and his tumor. Histologic data, stage and a drawing of the extension of the tumor are generally submitted to the radiotherapist. This study is intended to remind that some other factors are important for the radiooncologic decision about local and temporal dose distribution, such as tumor size, endometrial extension to the fundus, frequency of metastases and recurrences, different histology/grading, and performed surgical technique/radicality. The vital importance of these factors is explained. A new circular applicator is presented for routine afterloading irradiation with the selectron. The applicator has proved to be useful in practice. The problems of the afterloading technique as against the radium technique are indicated, especially with regard to the dose rate in point A.

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011832 Radiation Injuries Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES. Radiation Sickness,Radiation Syndrome,Injuries, Radiation,Injury, Radiation,Radiation Injury,Radiation Sicknesses,Radiation Syndromes,Sickness, Radiation,Sicknesses, Radiation,Syndrome, Radiation,Syndromes, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

J Halama, and H D Strüter, and B Rogge, and W Falk
December 1987, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
J Halama, and H D Strüter, and B Rogge, and W Falk
November 1986, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
J Halama, and H D Strüter, and B Rogge, and W Falk
June 1982, The British journal of radiology,
J Halama, and H D Strüter, and B Rogge, and W Falk
March 1993, The British journal of radiology,
J Halama, and H D Strüter, and B Rogge, and W Falk
January 1986, Geburtshilfe und Frauenheilkunde,
J Halama, and H D Strüter, and B Rogge, and W Falk
March 1964, New York state journal of medicine,
J Halama, and H D Strüter, and B Rogge, and W Falk
January 1978, Acta radiologica: oncology, radiation, physics, biology,
J Halama, and H D Strüter, and B Rogge, and W Falk
December 1987, The British journal of radiology,
J Halama, and H D Strüter, and B Rogge, and W Falk
December 2018, Cancer science,
J Halama, and H D Strüter, and B Rogge, and W Falk
July 1988, The British journal of radiology,
Copied contents to your clipboard!